Clinical trialNCT05997056RecruitingPhase 2Interventional

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

SponsorAadi Bioscience, Inc.Enrollment21Gastrointestinal Neuroendocrine TumorNETNeuroendocrine TumorsPancreatic Neuroendocrine TumorPulmonary Neuroendocrine Tumor

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 2 multi-center, open-label, single arm study of nab-sirolimus in patients with well-differentiated neuroendocrine tumors (NETs) of the gastrointestinal tract, lung, or pancreas who have not received prior treatment with mTOR inhibitors

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Willis Navarro, MD
Aadi Bioscience
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Michael Demeure, MD
Recruiting
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Allen Cohn, MD
Recruiting
Texas Oncology
Dallas, Texas, United States
Scott Paulson, MD
Recruiting
Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, United States
Alexandria T Phan, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Nab-sirolimus

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Nov 2023
Primary completion: 9 May 2025
Completion: 8 Dec 2025
Last update posted: 16 Jul 2024
Registered enrollment: 21
Registry id: NCT05997056

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.